Abstract
A method of acutely reducing the plasma level of PTH of a patient having an elevated PTH comprising the administration of a pharmaceutical composition comprising a GLP-2, or a variant, an analogue, or derivative of GLP-2 having the ability to bind and activate a GLP-2 receptor such as GLP-2 1-34
Original language | English |
---|---|
Patent number | US2010/0081,622 |
Filing date | 28/09/2009 |
Country/Territory | United States |
Publication status | Published - 1 Apr 2011 |
Keywords
- Faculty of Health and Medical Sciences